HHS has put forward a series of initiatives aimed at lowering drug prices, Medicare expenditures, and patient cost-sharing. The proposals run the gamut, from increasing transparency of net pricing, to allowing use of formulary tools previously off limits to Medicare plans, to direct price controls.
HHS’s Multi-Pronged Approach To Lower Drug Prices: Will It Work?
